info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Brain Aneurysm Treatment Market is Expected to Grow at a CAGR over ~ 13.5% from 2022 to 2030

Pune, India, May, 2023 /MRFR Press Release/- Market Research Future has a half cooked research report on the brain aneurysm treatment market.


Global Brain Aneurysm Treatment Market Highlights


It is estimated that brain aneurysm treatment market is expected to grow at a CAGR 13.5% during the forecast period of 2022-2030 and is projected to reach USD 6,223.8 Million by 2030. 


Brain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall. Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it. The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH). This kind of hemorrhage may lead to coma, stroke, and/or death. There are number of factors that contribute to the occurrence of brain aneurysms, such as cigarette smoking, injury or trauma, blood infections, and many others. Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.


A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market. Presence of brain aneurysm in the family history are also fuelling up the market to a great extent. According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%. Despite these drivers, there are some issues associated with brain aneurysm treatment market. High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent. Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.


Regional Analysis


The Americas dominates the brain aneurysm treatment market owing to the increasing prevalence of brain aneurysm. According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e. nearly 10 million individuals are living with brain aneurysm.


Europe holds the second largest market for brain aneurysm. It is expected that the support provided by government bodies for research & development and improvement in reimbursement policies in healthcare will drive the market in Europe region. Some cerebrovascular conditions are also very prevalent in the European region. According to a research study published in BMJ Open, it is found that Unruptured Intracranial Aneurysms (UIAs) is one of the most common cerebrovascular conditions in Germany. It is also estimated that nearly 1.6 million individuals in Germany are suffering from Unruptured intracranial aneurysms (UIAs).


Asia Pacific is the fastest growing brain aneurysm treatment market owing to the huge patient population and developing healthcare technology.


The Middle East & Africa holds the least share of brain aneurysm treatment market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Brain Aneurysm Treatment Market Research Report


Segmentation


The brain aneurysm treatment market is segmented on the basis of type, Condition, and end-user.


On the basis of type, market is segmented into surgery and medication. Surgery is further classified into surgical clipping, endovascular coiling, flow diverter, and others. Sub-segmentation of flow diverter includes pipeline embolization device, silk flow diverter (SILK), and surpass flow diverter (SURPASS). Sub-segmentation of medication includes anti-seizure medications, analgesics, calcium channel blockers, anti-hypertensives, anti-emetics, antacids, stool softeners, and others.


On the basis of condition, market is classified into unruptured aneurysm and ruptured aneurysm.


On the basis of end-users, market is segmented into hospital, clinics, and others.


Key Players


Some of key the players in the market are Medtronic Plc., Codman & Shurtleff, Inc., Raumedic AG, Vittamed, Sophysa Ltd., MicroPort Scientific Corporation, Orsan Medical Technologies, and Spiegelberg GmbH, Johnson & Johnson, Sophysa Ltd, HaiWeiKang, Head Sense Medical, InfraScan, Inc., Integra Life Sciences Corporation, and others.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Base Year 2023
Companies Covered 15
Pages 85
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.